Why and how people decide to stop taking prescribed psychiatric medication: exploring the subjective process of choice.

OBJECTIVE Despite the piling evidence supporting the effectiveness of psychiatric medication, research has consistently shown that only about half of those administered treatment actually take it as prescribed. The purpose of the present study was to explore why and how people with a serious mental illness (SMI) choose to stop taking prescribed medication. METHOD Seven persons with SMI who had been prescribed and had used medication in the past, but had not taken medication for at least a year, participated in semi-structured interviews, which were recorded and later transcribed. Qualitative analysis provided a foundation for sketching a hypothesized five-stage model of the process involved in choosing to stop medication. RESULTS This study revealed the subjective experience of taking medication, dilemmas it evokes, and the struggle to develop a personal perspective, plan and choice with regard to medication use. CONCLUSIONS Implications of these findings are discussed, emphasizing the importance of the "doctor-patient" relationship context.

[1]  Robert E. Drake,et al.  Shared Decision-Making and Evidence-Based Practice , 2006, Community Mental Health Journal.

[2]  Awad Ag.  Subjective Response to Neuroleptics in Schizophrenia , 1993 .

[3]  M. Tansella,et al.  How often do patients with psychosis fail to adhere to treatment programmes? A systematic review , 2003, Psychological Medicine.

[4]  J. Os,et al.  Medication adherence in psychosis: predictors and impact on outcome.A 2‐year follow‐up of first‐admitted subjects , 2000, Acta psychiatrica Scandinavica.

[5]  M. Lambert,et al.  Subjective well‐being under neuroleptic treatment and its relevance for compliance , 2005, Acta psychiatrica Scandinavica. Supplementum.

[6]  Mark Olfson,et al.  Interventions to improve medication adherence in schizophrenia. , 2002, The American journal of psychiatry.

[7]  G. Alexopoulos,et al.  Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. , 2001, Psychiatric services.

[8]  J. Trostle.  Medical compliance as an ideology. , 1988, Social science & medicine.

[9]  Robert E Drake,et al.  Shared decision making and medication management in the recovery process. , 2006, Psychiatric services.

[10]  J. Strauss.  The Person-Key to Understanding Mental Illness: Towards a New Dynamic Psychiatry, III , 1992, British Journal of Psychiatry.

[11]  Jan Scott,et al.  Treatment non‐adherence in affective disorders , 2002, Acta psychiatrica Scandinavica.

[12]  A. Buchanan.  A two-year prospective study of treatment compliance in patients with schizophrenia , 1992, Psychological Medicine.

[13]  C. Testa,et al.  Understanding treatment adherence in affective disorders: a qualitative study. , 2004, Journal of psychiatric and mental health nursing.

[14]  Anita Everett,et al.  Promoting the value and practice of shared decision-making in mental health care. , 2007, Psychiatric rehabilitation journal.

[15]  K. Usher,et al.  Taking neuroleptic medications as the treatment for schizophrenia: A phenomenological study. , 2001, The Australian and New Zealand journal of mental health nursing.

[16]  D. Goff,et al.  Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. , 2004, The Journal of clinical psychiatry.

[17]  C. Voils,et al.  Social support and locus of control as predictors of adherence to antidepressant medication in an elderly population. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[18]  B. Svarstad,et al.  Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. , 2000, Patient education and counseling.

[19]  Patricia E Deegan,et al.  The importance of personal medicine: A qualitative study of resilience in people with psychiatric disabilities , 2005, Scandinavian journal of public health. Supplement.

[20]  J. Addington,et al.  Medication adherence of individuals with a first episode of psychosis , 2002, Acta psychiatrica Scandinavica.

[21]  P. Bebbington.  The content and context of compliance , 1995, International clinical psychopharmacology.

[22]  Christian R. Dolder,et al.  Antipsychotic medication adherence: is there a difference between typical and atypical agents? , 2002, The American journal of psychiatry.

[23]  S. Strakowski,et al.  Factors associated with medication adherence in African American and white patients with bipolar disorder. , 2005, The Journal of clinical psychiatry.

[24]  M. Olfson,et al.  Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia. , 2006, Psychiatric services.

[25]  P. Lysaker,et al.  PATTERNS OF NEUROCOGNITIVE DEFICITS AND UNAWARENESS OF ILLNESS IN SCHIZOPHRENIA , 2003, The Journal of nervous and mental disease.

[26]  W S Fenton,et al.  Determinants of medication compliance in schizophrenia: empirical and clinical findings. , 1997, Schizophrenia bulletin.

[27]  J. Lieberman,et al.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.

[28]  A. Mitchell.  Depressed patients and treatment adherence , 2006, The Lancet.

[29]  T. Pachinger,et al.  Medication adherence among psychotic patients before admission to inpatient treatment. , 2004, Psychiatric services.

[30]  M. Lambert,et al.  Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence , 2004, European Psychiatry.